AETHLON MEDICAL, INC. Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture
AETHLON MEDICAL, INC. (AEMD) reported Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture of -$1.24 thousand for the 3-month period ending 2025-12-31, per its 10-Q filed 2026-02-12.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation · last filed 2026-02-12
- AETHLON MEDICAL, INC. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2025-12-31 was -$1.24K.
- AETHLON MEDICAL, INC. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2025-09-30 was -$3.34K.
- AETHLON MEDICAL, INC. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2025-06-30 was -$5.36K.
- AETHLON MEDICAL, INC. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2024-12-31 was -$7.07K.
| Period end | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture 3 month | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture 6 month | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture 9 month |
|---|---|---|---|
| 2025-12-31 | -$1.24K 10-Q · filed 2026-02-12 | -$4.58K derived: sum of 2 quarters · filed 2026-02-12 | -$9.94K derived: sum of 3 quarters · filed 2026-02-12 |
| 2025-09-30 | -$3.34K 10-Q · filed 2026-02-12 | -$8.70K derived: sum of 2 quarters · filed 2026-02-12 | |
| 2025-06-30 | -$5.36K 10-Q · filed 2026-02-12 | ||
| 2024-12-31 | -$7.07K 10-Q · filed 2026-02-12 | -$10.90K derived: sum of 2 quarters · filed 2026-02-12 | -$15.98K derived: sum of 3 quarters · filed 2026-02-12 |
| 2024-09-30 | -$3.83K 10-Q · filed 2026-02-12 | -$8.91K derived: sum of 2 quarters · filed 2026-02-12 | |
| 2024-06-30 | -$5.08K 10-Q · filed 2026-02-12 | ||
| 2023-12-31 | -$9.37K 10-Q · filed 2025-02-12 | -$19.22K derived: sum of 2 quarters · filed 2025-02-12 | -$27.59K derived: sum of 3 quarters · filed 2025-02-12 |
| 2023-09-30 | -$9.84K 10-Q · filed 2025-02-12 | -$18.21K derived: sum of 2 quarters · filed 2025-02-12 | |
| 2023-06-30 | -$8.37K 10-Q · filed 2025-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |